期刊文献+

^(18)F-FDG PET-CT在寻找转移瘤原发灶中的临床价值 被引量:7

The role of ^(18)F-FDG PET-CT in the detection of primary lesions for patients with tumor metastasis
暂未订购
导出
摘要 目的:本研究旨在探讨18F-FDG PET-CT对转移瘤患者原发灶诊断中的价值。方法:回顾性分析164例经病理学检查证实为转移的不明原发灶肿瘤患者为寻找原发灶而行18F-FDG PET-CT检查,待最终随访结束后对所有数据、资料进行统计处理分析。结果:18F-FDG PET-CT对肿瘤原发灶总检出率为51.2%(84/164),特异性97.3%(71/73),敏感性92.3%(84/91),准确度94.5%(155/164),阴性预测值91.0%(71/78),阳性预测值97.7%(84/86)。PET-CT对转移性腺癌、转移性鳞癌、转移性未分化癌3组常见病理类型转移瘤的原发灶检出率分别为54.0%(47/87)、56.8%(21/37)、40.0%(12/30)。经统计分析,3组转移瘤原发灶检出率之间无统计学差异。结论:18F-FDG PET-CT在寻找不明原发灶肿瘤原发灶中具有重要价值。 Objective: To evaluate the ISF-FDG PET-CT in detecting primary foci in cases of suspected metastatic tumor. Methods: One hundred and sixty-four patients with pathologically proved metastasis of unknown primary tumor underwent ^18F- FDG PET-CT scan. Statistical analysis was performed after the final follow up. Result: The total positive rate, specificity, sen- sitivity, accuracy, negative predictive value and positive predictive value were 51.2%(84/164), 97.3%(71/73), 92.3%(84/91), 94.5%(155/164), 91.0%(71/78), 97.7%(84/86) respectively. The positive rate of the primary loci for metastatic adenoeareinoma, metastatic squamous carcinoma and metastatic undifferentiated carcinoma were 54.0%(47/87), 56.8%(21/37) and 40.0%(12/30) respectively. According to the statistical analysis, there was no statistical difference among the positive rate of the three groups. Conclusion: ^18F-FDG PET-CT might be of importance in 'the detection of primary site in unknown primary tumors
出处 《中国临床医学影像杂志》 CAS 2012年第10期722-726,共5页 Journal of China Clinic Medical Imaging
关键词 肿瘤 未知原发灶 氟脱氧葡萄糖F18 正电子发射断层显像术 体层摄影术 螺旋计算机 Neoplasms, unknown primary Fluorodeoxyglucose F18 Positron-emission tomography Tomography, spiral computed
  • 相关文献

参考文献11

  • 1Park JS,Yim JJ,Kang WJ. Detection of primary sites in unknown primary tumors using FDG-PET or FDG-PET/CT[J].BMC Res Notes,2011,(01):56.
  • 2Natoli C,Ramazzotti V,Nappi O. Unknown primary tumors[J].Biochimica Et Biophysica Acta,2011,(01):13-24.
  • 3Kwee TC,Basu S,Gang Cheng. FDG PET/CT in carcinoma of unknown primary[J].European Journal of Nuclear Medicine and Molecular Imaging,2010,(03):635-644.
  • 4Amhrosini V,Nanni C,Rubello D. 18F-FDG PET/CT in the assessment of carcinoma of unknown primary origin[J].La Radiologia Medica,2006,(08):1146-1155.
  • 5Nanni C,Rubello D,Castellucci P. Role of 18F-FDG PETCT imaging for the detection of an unknown primary tumour:preliminary results in 21 patients[J].European Journal of Nuclear Medicine and Molecular Imaging,2005,(05):589-592.doi:10.1007/s00259-004-1734-3.
  • 6Dong MJ,Zhao K,Lin XT. Role of fluorodexyglucose-PET versus fluorodexyglucose-PET/computed tomography in detection of unknown primary tumor:a meta-analysis of the literature[J].Nuclear Medicine Communications,2008,(09):791-802.
  • 7Delbeke D,Coleman RE,Guiberteau M J. Procedure guideline for tumor imaging with 18F-FDG PET/CT 1.0[J].Journal of Nuclear Medicine,2006,(05):885-895.
  • 8Seve P,Billotey C,Broussolle C. The role of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in disseminated carcinoma of unknown primary site[J].Cancer,2007,(02):292-299.
  • 9Kwee TC,Kwe RM. Combined FDG-PET/CT for the detection of unknown primary tumors:systematic review and meta-analysis[J].European Journal of Radiology,2009,(03):731-744.
  • 10郑容,吴宁,李静,张雯杰,刘瑛,赵平.^(18)F-FDG PET/CT显像在寻找转移性肿瘤原发灶中的应用[J].中国临床医学影像杂志,2008,19(3):164-167. 被引量:9

二级参考文献26

  • 1徐海峰,周润锁,袁梦晖,张金赫,王磊,周飞华.^(18)F-双脱氧葡萄糖全身PET显像寻找肿瘤原发灶的诊断价值[J].第四军医大学学报,2004,25(17):1618-1620. 被引量:8
  • 2李亚军,高硕,陈秋松,李彦生,邢喜玲.^(18)F-FDGPET/CT显像探测原发肿瘤病灶的临床价值[J].中华核医学杂志,2005,25(1):37-38. 被引量:10
  • 3van de Wouw AJ, Janssen-Heijnen NIL, Coebergh JW, et al. Epidemiology of unknown primary tumours: incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984-1992[J]. Eur J Cancer, 2002, 38(3): 409-413
  • 4Pavlidis N, Briasoulis E, Hainsworth J, et al. Diagnostic and therapeutic management of cancer of an unknown primary[J]. Eur J Cancer, 2003, 39(14): 1990-2005
  • 5Rohren EM, Lowe VJ. Update in PET imaging of nonsmall cell lung cancer[J]. Semin Nucl Med, 2004, 34(2): 134-153
  • 6Pepe G, Rossetti C, Sironi S, et al. Patients with known or suspected lung cancer: evaluation of clinical management changes due to 18F-fluorodeoxyglucose positron emission tomography (^18F-FDG PET) study[J]. Nucl Med Commun, 2005, 26(9): 831-837
  • 7Bunyaviroch T, Coleman RE. PET evaluation of lung cancer[J]. J Nucl Med, 2006, 47(3):451-469
  • 8Gutzeit A, Antoch G, Kuhl H, et al. Unknown Primary Tumors: Detection with Dual-Modality PET/CT-Initial Experience [J]. Radiology, 2005, 234(1):227-234
  • 9Regelink G, Brouwer J, de Bree R, et al. Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities[J]. Eur J Nucl Med Mol Imaging, 2002, 29(8): 1024-1030
  • 10Wong WL, Saunders M. The Impact of FDG PET on the Management of Occult Primary Head and Neck T umours[J]. Clin Oncol(R Coll Radiol), 2003, 15(8): 461-466

共引文献19

同被引文献58

引证文献7

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部